205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.37%
Negative revenue growth while QCOM stands at 92.31%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-66.16%
Negative gross profit growth while QCOM is at 92.31%. Joel Greenblatt would examine cost competitiveness or demand decline.
12.50%
EBIT growth below 50% of QCOM's 144.38%. Michael Burry would suspect deeper competitive or cost structure issues.
12.50%
Operating income growth under 50% of QCOM's 144.38%. Michael Burry would be concerned about deeper cost or sales issues.
3.57%
Net income growth of 3.57% while QCOM is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
-9.17%
Negative EPS growth while QCOM is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-9.17%
Negative diluted EPS growth while QCOM is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-3.70%
Share reduction while QCOM is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-3.70%
Reduced diluted shares while QCOM is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
12.88%
Dividend growth of 12.88% while QCOM is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-90.30%
Negative OCF growth while QCOM is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-135.76%
Negative FCF growth while QCOM is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
38.03%
10Y revenue/share CAGR under 50% of QCOM's 93.97%. Michael Burry would suspect a lasting competitive disadvantage.
38.03%
5Y revenue/share CAGR under 50% of QCOM's 93.97%. Michael Burry would suspect a significant competitive gap or product weakness.
12.06%
3Y revenue/share CAGR under 50% of QCOM's 93.97%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-298.66%
Negative 10Y net income/share CAGR while QCOM is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-298.66%
Negative 5Y net income/share CAGR while QCOM is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-163.05%
Negative 3Y CAGR while QCOM is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.37%
3Y dividend/share CAGR of 76.37% while QCOM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.93%
Firm’s AR is declining while QCOM shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.82%
Inventory growth of 2.82% while QCOM is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
0.20%
Asset growth of 0.20% while QCOM is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
0.63%
BV/share growth of 0.63% while QCOM is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
18.67%
Debt growth of 18.67% while QCOM is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-7.20%
We cut SG&A while QCOM invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.